265 related articles for article (PubMed ID: 30881500)
1. Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer.
Zhang Q; Nong J; Wang J; Yan Z; Yi L; Gao X; Liu Z; Zhang H; Zhang S
Oncol Lett; 2019 Apr; 17(4):3799-3807. PubMed ID: 30881500
[TBL] [Abstract][Full Text] [Related]
2. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres.
Wang SG; Zhang B; Li CG; Zhu JQ; Sun BS; Wang CL
Thorac Cancer; 2020 Oct; 11(10):2887-2895. PubMed ID: 32856417
[TBL] [Abstract][Full Text] [Related]
3. Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
Liu HE; Vuppalapaty M; Wilkerson C; Renier C; Chiu M; Lemaire C; Che J; Matsumoto M; Carroll J; Crouse S; Hanft VR; Jeffrey SS; Di Carlo D; Garon EB; Goldman J; Sollier E
Front Oncol; 2020; 10():572895. PubMed ID: 33117705
[TBL] [Abstract][Full Text] [Related]
4. [Single-cell detection of EGFR gene mutation in circulating tumor cells in lung cancer].
Sun S; Deng YL
Yi Chuan; 2015 Dec; 37(12):1251-7. PubMed ID: 26704950
[TBL] [Abstract][Full Text] [Related]
5. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
[TBL] [Abstract][Full Text] [Related]
6. Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood.
Ran R; Li L; Wang M; Wang S; Zheng Z; Lin PP
Anal Bioanal Chem; 2013 Sep; 405(23):7377-82. PubMed ID: 23828210
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip.
Gao W; Huang T; Yuan H; Yang J; Jin Q; Jia C; Mao G; Zhao J
Talanta; 2018 Aug; 185():229-236. PubMed ID: 29759193
[TBL] [Abstract][Full Text] [Related]
8. [Detection of circulating tumor cells with chromosomes 7 and 8 polysomy in non-small cell lung cancer and its correlation with epidermal growth factor receptor mutations in cancer tissue].
Jiang XR; Lu J; Gu YJ; Li YL; Zhao SL; Jin ML
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):447-452. PubMed ID: 33915649
[No Abstract] [Full Text] [Related]
9. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
Gasch C; Bauernhofer T; Pichler M; Langer-Freitag S; Reeh M; Seifert AM; Mauermann O; Izbicki JR; Pantel K; Riethdorf S
Clin Chem; 2013 Jan; 59(1):252-60. PubMed ID: 23136247
[TBL] [Abstract][Full Text] [Related]
10. EGFR mutation detection of lung circulating tumor cells using a multifunctional microfluidic chip.
Wang Y; Gao W; Wu M; Zhang X; Liu W; Zhou Y; Jia C; Cong H; Chen X; Zhao J
Talanta; 2021 Apr; 225():122057. PubMed ID: 33592778
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.
Markou AN; Londra D; Stergiopoulou D; Vamvakaris I; Potaris K; Pateras IS; Kotsakis A; Georgoulias V; Lianidou E
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980762
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
[TBL] [Abstract][Full Text] [Related]
13. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
[TBL] [Abstract][Full Text] [Related]
14. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
[TBL] [Abstract][Full Text] [Related]
15. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC.
Lim M; Park J; Lowe AC; Jeong HO; Lee S; Park HC; Lee K; Kim GH; Kim MH; Cho YK
Theranostics; 2020; 10(12):5181-5194. PubMed ID: 32373206
[No Abstract] [Full Text] [Related]
16. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
[TBL] [Abstract][Full Text] [Related]
17. Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR.
Ntzifa A; Kotsakis A; Georgoulias V; Lianidou E
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073111
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
19. Cross-Platform Comparison of Four Leading Technologies for Detecting
Xu T; Kang X; You X; Dai L; Tian D; Yan W; Yang Y; Xiong H; Liang Z; Zhao GQ; Lin S; Chen KN; Xu G
Theranostics; 2017; 7(6):1437-1446. PubMed ID: 28529628
[TBL] [Abstract][Full Text] [Related]
20. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.
Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT
Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
